Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Be Well: How to Identify Signs of An Eating Disorder
Be Well: How to Forge A Better Relationship With Money
Be Well: Building Strength and Endurance With the AMRAP Routine
Be Well: How to Select the Perfect Vitamins & Supplements
Be Well: Understanding Strokes and Knowing the Warning Signs
AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
Elon Musk's brain-implant company Neuralink said it received approval from the Food and Drug Administration to begin human clinical trials.
Shares of e-commerce giant Alibaba fell as China braces for a new wave of Covid.
New Census figures show about 1 in every 100 U.S. households is a same-sex couple.
Dr. Caitlin Bernard is facing disciplinary action after she spoke publicly about providing an abortion to a 10-year-old rape victim.
